Recommendations for the management of diarrhea with trofinetide use in Rett syndrome

References

• Amir RE, Van den Veyver IB, Wan M, et al. Rett syndrome is caused by mutations in X- linked MECP2, encoding methyl- CpG-binding protein 2. Nat Genet. 1999;23(2):185–188. DOI:10.1038/13810
   PubMed Web of Science ®Google Scholar
• Hagberg B. Clinical manifestations and stages of Rett syndrome. Ment Retard Dev Disabil Res Rev. 2002;8(2):61–65. DOI:10.1002/mrdd.10020
   PubMedGoogle Scholar
• Percy A. Rett syndrome: coming to terms with treatment. Adv Neurosci. 2014;2014:345270.
   Google Scholar
• Neul JL, Kaufmann WE, Glaze DG, et al. Rett syndrome: revised diagnostic criteria and nomenclature. Ann Neurol. 2010;68(6):944–950. DOI:10.1002/ana.22124
   PubMed Web of Science ®Google Scholar
• Fu C, Armstrong D, Marsh E, et al. Multisystem comorbidities in classic Rett syndrome: a scoping review. BMJ Paediatr Open. 2020;4(1):e000731. DOI:10.1136/bmjpo-2020-000731
   PubMedGoogle Scholar
• Williams JG, Roberts SE, Ali MF, et al. Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence. Gut. 2007 Feb;56(Suppl 1):1–113.
   PubMed Web of Science ®Google Scholar
• Motil KJ, Caeg E, Barrish JO, et al. Gastrointestinal and nutritional problems occur frequently throughout life in girls and women with Rett syndrome. J Pediatr Gastroenterol Nutr. 2012;55(3):292–298. DOI:10.1097/MPG.0b013e31824b6159
   PubMed Web of Science ®Google Scholar
• Baikie G, Ravikumara M, Downs J, et al. Gastrointestinal dysmotility in Rett syndrome. J Pediatr Gastroenterol Nutr. 2014;58(2):237–244. DOI:10.1097/MPG.0000000000000200
   PubMed Web of Science ®Google Scholar
• Collins BE, Neul JT. Glycine-proline-glutamate (GPE) analogue, treatment of Rett syndrome, treatment of fragile X syndrome. Drugs Future. 2021;46(1):29.
   Web of Science ®Google Scholar
• Bickerdike MJ, Thomas GB, Batchelor DC, et al. NNZ-2566: a Gly- Pro-Glu analogue with neuroprotective efficacy in a rat model of acute focal stroke. J Neurol Sci. 2009;278(1–2):85–90. DOI:10.1016/j.jns.2008.12.003
   PubMed Web of Science ®Google Scholar
• Tropea D, Giacometti E, Wilson NR, et al. Partial reversal of Rett Syndrome- like symptoms in MeCP2 mutant mice. Proc Natl Acad Sci U S A. 2009;106(6):2029–2034. DOI:10.1073/pnas.0812394106
   PubMed Web of Science ®Google Scholar
• Neul JL, Percy AK, Benke TA, et al. Design and outcome measures of LAVENDER, a phase 3 study of trofinetide for Rett syndrome. Contemp Clin Trials. 2022;114:106704.
   PubMed Web of Science ®Google Scholar
• Neul JL, Percy AK, Benke TA, et al. Trofinetide for the treatment of Rett syndrome: a randomized phase 3 study. Nat Med. 2023. DOI:10.1038/s41591-023-02398-1
   PubMed Web of Science ®Google Scholar
• Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol. 1997 Sep;32(9):920–924.
   PubMed Web of Science ®Google Scholar
• Lenhart A, Chey WD. A systematic review of the effects of polyols on gastrointestinal health and irritable bowel syndrome. Adv Nutr. 2017;8(4):587–596.
   PubMed Web of Science ®Google Scholar
• Borghi E, Borgo F, Severgnini M, et al. Rett syndrome: a focus on gut microbiota. Int J Mol Sci. 2017;18(2):344. DOI:10.3390/ijms18020344
   PubMed Web of Science ®Google Scholar
• Hattori K, Akiyama M, Seki N, et al. Gut microbiota prevents sugar alcohol- induced diarrhea. Nutrients. 2021;13(6):2029. DOI:10.3390/nu13062029
   PubMed Web of Science ®Google Scholar
• Strati F, Cavalieri D, Albanese D, et al. Altered gut microbiota in Rett syndrome. Microbiome. 2016;4(1):41. DOI:10.1186/s40168-016-0185-y
   PubMedGoogle Scholar
• Lambeau KV, McRorie JW Jr. Fiber supplements and clinically proven health benefits: how to recognize and recommend an effective fiber therapy. J Am Assoc Nurse Pract. 2017;29(4):216–223.
   PubMed Web of Science ®Google Scholar
• McRorie JW Jr, McKeown NM. Understanding the physics of functional fibers in the gastrointestinal tract: an evidence- based approach to resolving enduring misconceptions about insoluble and soluble fiber. J Acad Nutr Diet. 2017;117(2):251–264.
   PubMed Web of Science ®Google Scholar
• Senderovich H, Vierhout M. Is there a role for bismuth in diarrhea management? Rambam Maimonides Med J. 2021 Jan 19;12(1):e0002.
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration. Labeling for oral and rectal over-the-counter drug products containing aspirin and nonaspirin salicylates; Reye’s Syndrome warning. Final rule. Fed Regist. 2003;68(74):18861–18869.
   PubMedGoogle Scholar
• Fleisher GR, O’Ryan MG. Patient education: acute diarrhea in children (beyond the basics). UpToDate [Internet] 2022 [updated 2022 Jun 27; cited 2022 Jun 27]. Available from: https://www.uptodate.com/contents/acute-diarrhea-in-children-beyond-the-basics.
   Google Scholar
• King CK, Glass R, Bresee JS, et al. Managing acute gastroenteritis among children. MMWR Recomm Rep. 2003;52(RR16):1–16.
   PubMedGoogle Scholar
• Ward CS, Huang TW, Herrera JA, et al. Loss of MeCP2 causes urological dysfunction and contributes to death by kidney failure in mouse models of Rett syndrome. PLoS ONE. 2016;11(11):e0165550. DOI:10.1371/journal.pone.0165550
   PubMed Web of Science ®Google Scholar
• Corte T, Bonella F, Crestani B, et al. Safety, tolerability and appropriate use of nintedanib in idiopathic pulmonary fibrosis. Respir Res. 2015 Sep;16(1):116.
   PubMedGoogle Scholar
• Cottin V, Martinez FJ, Jenkins RG, et al. Safety and tolerability of nintedanib in patients with progressive fibrosing interstitial lung diseases: data from the randomized controlled INBUILD trial. Respir Res. 2022 Apr 7;23(1):85.
   PubMed Web of Science ®Google Scholar
• Parikh P, Prabhash K, Naik R, et al. Practical recommendation for rash and diarrhea management in Indian patients treated with tyrosine kinase inhibitors for the treatment of non- small cell lung cancer. Indian J Cancer. 2016 Jan;53(1):87–91.
   PubMed Web of Science ®Google Scholar
• Hirsh V, Blais N, Burkes R, et al. Management of diarrhea induced by epidermal growth factor receptor tyrosine kinase inhibitors. Curr Oncol. 2014 Dec;21(6):329–336.
   PubMed Web of Science ®Google Scholar
• Clay PG, Crutchley RD. Noninfectious diarrhea in HIV seropositive individuals: a review of prevalence rates, etiology, and management in the era of combination antiretroviral therapy. Infect Dis Ther. 2014 Dec;3(2):103–122.
   PubMedGoogle Scholar
• Rachlis A, Gill J, Baril JG, et al. Effectiveness of step- wise intervention plan for managing nelfinavir- associated diarrhea: a pilot study. HIV Clin Trials. 2005 Jul;6(4):203–212.
   PubMed Web of Science ®Google Scholar
• Bliss DZ, Jung HJ, Savik K, et al. Supplementation with dietary fiber improves fecal incontinence. Nurs Res. 2001 Jul;50(4):203–213.
   PubMed Web of Science ®Google Scholar
• Bliss DZ, Savik K, Jung HJ, et al. Dietary fiber supplementation for fecal incontinence: a randomized clinical trial. Res Nurs Health. 2014 Oct;37(5):367–378.
   PubMed Web of Science ®Google Scholar
• Emery EA, Ahmad S, Koethe JD, et al. Banana flakes control diarrhea in enterally fed patients. Nutr Clin Pract. 1997 Apr;12(2):72–75.
   PubMedGoogle Scholar
• Heather DJ, Howell L, Montana M, et al. Effect of a bulk- forming cathartic on diarrhea in tube- fed patients. Heart Lung. 1991 Jul;20(4):409–413.
   PubMed Web of Science ®Google Scholar
• Zimmaro DM, Rolandelli RH, Koruda MJ, et al. Isotonic tube feeding formula induces liquid stool in normal subjects: reversal by pectin. JPEN J Parenter Enteral Nutr. 1989 Mar;13(2):117–123.
   PubMed Web of Science ®Google Scholar
• Bernaola Aponte G, Bada Mancilla CA, Carreazo NY, et al. Probiotics for treating persistent diarrhoea in children. Cochrane Database Syst Rev. 2013;2013(8):CD007401. DOI:10.1002/14651858.CD007401.pub3
   PubMedGoogle Scholar
• Varughese CA, Vakil NH, Phillips KM. Antibiotic-associated diarrhea: a refresher on causes and possible prevention with probiotics—continuing education article. J Pharm Pract. 2013;26(5):476–482.
   PubMedGoogle Scholar
• Darwish M, Youakim JM, Harlick J, et al. A phase 1, open- label study to evaluate the effects of food and evening dosing on the pharmacokinetics of oral trofinetide in healthy adult subjects. Clin Drug Investig. 2022;42(6):513–524. DOI:10.1007/s40261-022-01156-4
   PubMed Web of Science ®Google Scholar
• Berry-Kravis E, Horrigan JP, Tartaglia N, et al. A double-blind, randomized, placebo- controlled clinical study of trofinetide in the treatment of Fragile X Syndrome. Pediatr Neurol. 2020 Sep;110:30–41.
   PubMed Web of Science ®Google Scholar
• Glaze DG, Neul JL, Percy A, et al. A double- blind, randomized, placebo- controlled clinical study of trofinetide in the treatment of Rett syndrome. Pediatr Neurol. 2017;76:37–46.
   PubMed Web of Science ®Google Scholar
• Glaze DG, Neul JL, Kaufmann WE, et al. Double-blind, randomized, placebo- controlled study of trofinetide in pediatric Rett syndrome. Neurology. 2019;92(16):e1912–1925. DOI:10.1212/WNL.0000000000007316
   PubMed Web of Science ®Google Scholar
• Darwish M, Youakim J, Darling I, et al. Limited potential for interactions between trofinetide, an investigational agent for treatment of Rett syndrome, and antiseizure medications metabolized by CYP3A4. Presented at: 75th Annual Meeting of the American Epilepsy Society; 2021 Dec 3-7; Chicago, IL.
   Google Scholar